CD69 and hepatocellular carcinoma: FACS results confirmed the activated state of FcγRIIlow/− B cells as following: most FcγRIIlow/− B cells from HCC tumours displayed a CD69+BTLA− activated phenotype with reduced B-cell follicle homing molecules CD62L, CXCR5 and CCR6.